![1]() - Opinion- COVID-19 and the superspreaders: Teens- October 8, 2020- Director of adolescent medicine at Children’s Wisconsin in Milwaukee, Margaret Thew shares her experience with teen behavior regarding COVID-19. 
- News- Pediatric fractures shift during pandemic- October 8, 2020- Yet there were more bone fractures at home and on bicycles, and more fractures in younger children. 
![1]() - News- One measure of child COVID-19 may be trending downward- October 8, 2020- Percentage of weekly cases occurring in children has dropped for 2 consecutive weeks. 
- News- CMS gives hospitals 14 weeks to start daily COVID, flu reports- October 7, 2020- The Centers for Medicare & Medicaid Services (CMS) will send letters on October 7 to all 6,200 hospitals that receive reimbursement from the two federal health programs informing them of how well they are doing now. 
![1]() - News- Optimal sedation strategies for COVID-19 ICU patients: A work in progress- October 7, 2020- “Clinicians should consider using adjuvant agents to limit opioid exposure and improve pain scores in the critically ill,” Dr. Steven B. Greenberg said. 
![1]() - Opinion- 2020 has been quite a year- October 7, 2020- Hospitalists have been incredibly resilient and innovative since the COVID-19 pandemic arrived in the United States. 
- News- FDA posts COVID vaccine guidance amid White House pushback- October 7, 2020- In the new guidance document, FDA officials outline what will be required for even a limited clearance, known as an emergency use authorization, for a COVID-19 vaccine. 
![1]() - News- INR fails to predict bleeding in patients with cirrhosis- October 6, 2020- The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients. 
![1]() - News- EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan- October 6, 2020- Empagliflozin treatment of HFrEF was equally beneficial regardless of whether patients also received sacubitril/valsartan. 
![1]() - News- HM20 Virtual: Key takeaways for the pediatric hospitalist- October 6, 2020- Here are some key concepts and takeaways from HM20 Virtual for the pediatric hospitalist. 






